Improving fMRI in Parkinson’s disease by accounting for brain region-specific activity patterns
Renzo Torrecuso(Max Planck Institute for Human Cognitive and Brain Sciences), Harald E. Möller(Max Planck Institute for Human Cognitive and Brain Sciences), Matthias L. Schroeter(Max Planck Institute for Human Cognitive and Brain Sciences), Robert Jech(Charles University), Štefan Holiga(Roche (Switzerland)), Evžen Růžička(Charles University), Filip Růžička(Charles University), Karsten Mueller(Max Planck Institute for Human Cognitive and Brain Sciences), Tomáš Sieger(Charles University), Josef Vymazal(Na Homolce Hospital), Jan Roth(Charles University)
Cited by 6
Related Papers
<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's disease
|European Journal of Neurology|2012|490
MRI of the lungs using hyperpolarized noble gases
|Magnetic Resonance in Medicine|2002|396
The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany
|BMC Public Health|2015|374
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
|Neurology|2005|273
Trial of Deferiprone in Parkinson’s Disease
|New England Journal of Medicine|2022|226